FDA ANDA · ANDA213796
DOXEPIN HYDROCHLORIDE
Sponsor: ADAPTIS
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA213796
TYPE
ANDA
ORIGINAL APPROVAL
2022-04-19
LATEST ACTION
2026-10-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
DOXEPIN HYDROCHLORIDEDiscontinued
DOXEPIN HYDROCHLORIDE EQ 150MG BASE · CAPSULE · ORAL
Approval history
2026-10-05Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →